Auditory-Cognitive Optimization Care Program for Older Adults With Hearing Loss and Cognitive Impairment
Key facts
- Where
- Taipei, TaiwanSee the site
Where in Taiwan
- Taipei Medical University HospitalTaipei, TaiwanContact: Jia-You Ye, Ph.DNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Taipei Medical University
- Trial code
- NCT07869745
- Record updated
- 13 October 2026
- Original description
Hearing loss and cognitive impairment are common and interrelated health problems that may affect communication, information processing, attention, psychological well-being, daily functioning, and quality of life. This study aims to develop and evaluate a comorbidity-oriented Auditory-Cognitive Optimization Care Program (A-COP) for individuals with hearing loss and cognitive impairment.Read full original descriptionShow less
Development and Evaluation of a Comorbidity-Oriented Auditory-Cognitive Optimization Care Program (A-COP) for Individuals With Hearing Loss and Cognitive Impairment: A Longitudinal, Single-Blind, Two-Arm, Parallel-Group Randomized Controlled Trial
Hearing loss and cognitive impairment are common and interrelated health problems that may affect communication, information processing, attention, psychological well-being, daily functioning, and quality of life. This study aims to develop and evaluate a comorbidity-oriented Auditory-Cognitive Optimization Care Program (A-COP) for individuals with hearing loss and cognitive impairment.
The A-COP will be developed based on evidence from a literature review and findings from qualitative research involving individuals with hearing loss and cognitive impairment and their caregivers. The program integrates hearing-related care and cognitive stimulation strategies to address the combined needs associated with hearing and cognitive difficulties.
In the intervention phase, participants will be randomly assigned to either the A-COP intervention group or an active control group in a two-arm, parallel-group randomized controlled trial. The study will evaluate changes in cognitive function, hearing and communication-related outcomes, depressive symptoms, and quality of life from baseline through the 6-month follow-up. The findings will provide evidence regarding the effects of the A-COP in individuals with hearing loss and cognitive impairment.
Inclusion: Aged 60 years or older and able to communicate in Mandarin Chinese or Taiwanese; Self-reported hearing and cognitive decline and able to complete hearing, communication, and cognitive assessments; HHIE-S score ≥9, followed by pure-tone audiometry, and HI-MoCA score of 18-24; Hearing loss confirmed by an otolaryngologist, defined as a pure-tone average at 0.5, 1, 2, and 4 kHz of ≥21 dB HL in the better-hearing ear; Willing to participate voluntarily and provide written informed consent after receiving an explanation of the study purpose, procedures, potential risks, and participant rights.
Exclusion: Received structured cognitive stimulation, cognitive training, cognitive rehabilitation, or related care or treatment within the previous 6 months; Severe psychiatric illness, significant behavioral problems, or other conditions judged by a physician to interfere with participation in the study procedures or intervention activities; Severe visual, hearing, or communication impairment that prevents understanding of the study information or completion of the assessment measures.